Aravive Inc (NASDAQ:ARAV)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ARAV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ARAV

  • Market Cap$93.310m
  • SymbolNASDAQ:ARAV
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS03890D1081

Company Profile

Aravive Inc is a clinical-stage biotechnology company. It focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies. The company's lead candidate AVB-500 is developed as a targeted therapy against ovarian cancer.Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Latest ARAV news

Currently there for this company. Visit our news hub for other news .